L9 BioScience Inc.
Providing patients with safer and more effective medicines
What we do:
L9 BioScience is a technology that increases the bioavailability of Active Pharmaceutical Ingredients (API’s)
9-fold to 18-fold increase in API bioavailability
The L9 Process improves clinical outcomes, reduces toxicity and reduces cost
Up to 50% API retention without bioaccumulation
The L9 Process is patented, with 12 more discreet claims in the patent landscape
PHYSICAL IMPACT
A product with a higher gastric absorption level allows you to take exponentially smaller dosages of a given vitamin, pharmaceutical or nutraceutical. Pharmaceuticals and Nutraceuticals often have deleterious side effects, so smaller doses equates to significantly less deleterious side effects.
FINANCIAL IMPACT
The L9 Process allows one to re-patent originator drugs with new increased bioavailability.
The top 10 selling drugs whose patents have expired in 2020 total over $8 Billion. There are 56 drug patents expiring over the next 3 years.
This business model can be replicated over and over again with many other non-biological drugs, where drugs that have expired patents, may have the opportunity to be re-patented.
